Sponsored Dinner Symposium 19 July, 1830hrs

1. Personalising Breast Screening using AI

Mary Rickard, Consultant Radiologist , Sydney Breast Clinic

2. Finding Signal in the Noise – Applying AI and Ml to Health

Gabe Rijpma, Senior Director – Health and Social Services, Microsoft Asia

Free for all SBOSS and BreastDay participants. Limited seating. Kindly contact secretariat dinner symposium registration.

Sponsored Tea Symposium 20 July, 1030hrs

TAILORx – Identifying the Right Patients for the Right Treatment

Christy Russell, Senior Director US Medical Affairs, Genomic Health Inc

Tumour genomic analysis has made a substantial contribution to the treatment of breast cancers. The
traditional clinical parameters such as tumor size and grade are regarded as prognostic but not predictive. The Oncotype DX Breast Recurrence Score® test from Genomic Health Inc. in particular, has demonstrated its ability in guiding treatment decisions after breast surgery for hormone-receptor positive, HER2 negative breast cancer patients.
Dr Christy Russell will talk about the science of genomic testing in early breast cancers with the latest research data in the TAILORx trial.

Sponsored Lunch Symposium 20 July

Evolving Combination Strategies in Management of HR+ HER2- Advanced Breast Cancer

See Hui Ti

Sponsored Tea Symposium 20 July

A Surgeon’s Perspective on Targeted Treatment Strategies for Neoadjuvant HER2+ Early Breast Cancer

Ava Kwong, Chief of Division of Breast Surgery at Queen Mary Hospital, Tung Wah Hospital and The University of Hong Kong-Shenzhen Hospital